Tranol Injection (Tramadol Hydrochloride)
Tramadol Hydrochloride 50mg
Injections · Prescription medication
Teragen Etex Co., Ltd.
MFDS item code 201600211 · Notified 2016.01.12 · Insurance code 698503291
Relief of pain after diagnostic procedures or surgery, and moderate to severe acute and chronic pain (e.g., cancer)
This medication is used to relieve severe and moderate acute and chronic pain, for example, pain associated with various cancers or pain that occurs after diagnosis and surgery.
The dose of this medicine should be adjusted according to the intensity of the patient's pain and clinical response. In general, the lowest dose that relieves the pain should be administered. Adults After administering 50-100mg of tramadol hydrochloride per dose by intravenous or intramuscular injection, repeat the injection every 4-5 hours as needed. A maximum of 400mg may be administered per day. Older adults No dose adjustment is necessary in patients aged 75 years or younger with no clinically confirmed hepatic or renal impairment. In patients over 75 years of age, elimination of this medicine may be delayed; therefore, adjust the dosing interval as needed. Patients with renal impairment/on dialysis or hepatic impairment Elimination of this medicine may be delayed in patients with renal or hepatic impairment; therefore, consider extending the dosing interval in these patients.
Exceeding the recommended dosage may cause seizures. Caution should be exercised in patients with a history of epilepsy or those at risk of seizures, and it should only be used when necessary. Prolonged use may lead to psychological and physical dependence, thus it should be administered for a short period under strict supervision in patients with a history of substance abuse or dependence. Combination with alcohol or central nervous system depressants (such as benzodiazepines) can result in severe sedation, respiratory depression, coma, and even death, so it should be avoided or used with extreme caution. Patients with certain genetic variations may metabolize this medication faster, leading to increased blood levels and a higher risk of respiratory depression, therefore dosage adjustment or alternative medication should be considered for these patients. This medication should not be used in children under 12 years or in adolescents under 18 years who have undergone tonsillectomy or adenoidectomy. Should not be administered in cases of acute alcohol intoxication, central nervous system drug intoxication, severe respiratory depression, head injury, patients currently taking MAO inhibitors, patients with severe renal or hepatic impairment, and pregnant or breastfeeding women. Patients taking morphine, those with liver or kidney diseases, alcohol users, and those with a history of seizures must use this medication cautiously, and patients with a history of substance abuse or mental illness should also be monitored closely. This medication may cause side effects such as drowsiness, dizziness, nausea, and vomiting; therefore, activities such as driving or operating dangerous machinery should be avoided after administration. Prolonged use may lead to tolerance, requiring increased doses, and sudden discontinuation can provoke withdrawal symptoms; therefore, gradual dosage reduction should be implemented. This medication may interact with other central nervous system depressants, antidepressants, antipsychotics, etc., increasing the risk of side effects, so consultation with a physician is essential. It is advisable for pregnant or breastfeeding women to avoid this medication, particularly during lactation, as it may cause serious side effects in the baby. Overdosing may result in severe respiratory depression and seizures; immediate emergency treatment is required, and naloxone may be used as an antidote. It is safest not to use this medication in children, especially those under 12 years and in specific postoperative adolescents under 18 years. Elderly patients (75 years and older) may experience increased blood levels, thus the maximum daily dose should be limited. This medication must be stored out of reach of children and should be kept in the original container for safety.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in an airtight container to prevent exposure to air, and it is best kept at room temperature between 1 degree and 30 degrees Celsius. Storing in this manner helps maintain the medication's effectiveness.
A colorless injection containing a colorless liquid in a colorless transparent ampoule.
1 milliliter/ampoule [(1x50 ampoules)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Tramadol Hydrochloride 50mg
Injections · Prescription medication
Teragen Etex Co., Ltd.
Tramadol Hydrochloride 50mg
Prescription medication
(Yuhan Corporation)

Tramadol Hydrochloride 50mg
Hard capsule · Prescription medication
Yuhan Corporation
Tramadol Hydrochloride 50mg
Injections · Prescription medication
Hanol BioPharma Co., Ltd.
Tramadol Hydrochloride 50mg
Prescription medication
Il Sung IS Co., Ltd.
Tramadol Hydrochloride 100mg
Prescription medication
Il Sung IS Co., Ltd.
Tramadol Hydrochloride 50mg
Prescription medication
Ilseong IS Co., Ltd.
Tramadol Hydrochloride 50mg
Injections · Prescription medication
Donggwang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.